Alexander Osgerby Email

Process Development . Phico Therapeutics Ltd.

Current Roles

Employees:
22
Revenue:
$2M
About
Phico Therapeutics is developing a unique antibiotic technology to address one the most urgent challenges facing medicine today – how to destroy multi-drug resistant bacteria, the so-called “superbugs”. Phico's patented platform utilises an antibacterial protein, SASP to inactivate bacterial DNA and cause rapid destruction of target bacteria. SASPject™ is a new class of antibiotic which could provide many advantages over conventional antibiotic classes. Phico Therapeutics is based at Bourn, Cambridgeshire, UK
Phico Therapeutics Ltd. Address
Babraham Research Campus, Babraham
Bourn, null
Phico Therapeutics Ltd. Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.